US 11,786,560 B2
Immunoisolation device
Ariella Shikanov, Ann Arbor, MI (US)
Assigned to THE REGENTS OF THE UNIVERSITY OF MICHIGAN, Ann Arbor, MI (US)
Filed by THE REGENTS OF THE UNIVERSITY OF MICHIGAN, Ann Arbor, MI (US)
Filed on Jan. 11, 2021, as Appl. No. 17/146,089.
Application 17/146,089 is a continuation of application No. 15/755,242, granted, now 10,918,673, previously published as PCT/US2016/048673, filed on Aug. 25, 2016.
Claims priority of provisional application 62/211,175, filed on Aug. 28, 2015.
Prior Publication US 2021/0145895 A1, May 20, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/54 (2015.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61P 15/08 (2006.01)
CPC A61K 35/54 (2013.01) [A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 9/48 (2013.01); A61K 9/4816 (2013.01); A61K 9/50 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01); A61K 47/10 (2013.01); A61P 15/08 (2018.01)] 18 Claims
 
1. An immunoisolation device comprising:
a) an inner core comprising a cell; and
b) a non-degradable outer shell encapsulating the inner core,
wherein the non-degradable outer shell is the exterior layer of the immunoisolation device.